Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 6-7, Juin-Juillet 2009
Page(s) 622 - 626
Section M/S revues
DOI https://doi.org/10.1051/medsci/2009256-7622
Publié en ligne 15 juin 2009
  1. Picot S. Is Plasmodium vivax still a paradigm for uncomplicated malaria ? Med Mal Infect 2006; 36 : 406–13.
  2. World Health Organization. Word Malaria Report 2008. Geneva : WHO, 2008.
  3. Picard J, Mills A. The effect of malaria on work time: analysis of data from two Nepali districts. J Trop Med Hyg 1992; 95 : 382–9.
  4. Mendis K, Sina BJ, Marchesini P, et al. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001; 64 : 97–106.
  5. Hay SI, Guerra CA, Tatem AJ, et al. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004; 4 : 327–36.
  6. Carlton JM, Adams JH, Silva JC, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008; 455 : 757–63.
  7. Ntumngia FB, McHenry AM, Barnwell JW, et al. Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am J Trop Med Hyg 2009; 80 : 218–27.
  8. Labie D. Polymorphismes de Plasmodium vivax. Comment les interpréter ? Quelles incidences en santé publique aujourd’hui ? Med Sci (Paris) 2005; 21 : 123–4.
  9. Collins WE, Sullivan JS, Jeffery GM, et al. The Chesson strain of Plasmodium vivax in humans and different species of Aotus monkeys. Am J Trop Med Hyg 2009; 80 : 152–9.
  10. White NJ. Plasmodium knowlesi: the fifth human malaria parasite. Clin Infect Dis 2008; 46 : 172–3.
  11. Cox-Singh J, Davis TM, Lee KS, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008; 46 : 165–71.
  12. Oliver M, Simon F, de Monbrison F, et al. New use of primaquine for malaria. Med Mal Infect 2008; 38 : 169–79.
  13. Huldén L, Huldén L. Dynamics of positional warfare malaria: Finland and Korea compared. Malar J 2008; 7 :171.
  14. Chen N, Auliff A, Rieckmann K, et al. Relapses of Plasmodium vivax infection result from clonal hypnozoïtes activated at predetermined intervals. J Infect Dis 2007; 195 : 934–41.
  15. Alves FP, Durlacher RR, Menezes MJ, et al. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 2002; 66 : 641–8.
  16. Karunaweera ND, Wijesekera SK, Wanasekera D, et al. The paroxysm of Plasmodium vivax malaria. Trends Parasitol 2003; 19 : 188–93.
  17. Elliott JH, O’Brien D, Leder K, et al. Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers. J Travel Med 2004; 11 : 213–7.
  18. Mühlberger N, Jelinek T, Gascon J, et al. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J 2004; 8 : 3–5.
  19. Barcus MJ, Basri H, Picarima H, et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 2007; 77 : 984–91.
  20. Genton B, D’Acremont V, Rare L, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008; 5 : 881–9.
  21. Tjitra E, Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 2008; 5 : e128.
  22. Kochar DK, Das A, Kochar SK, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 2009; 80 : 194–8.
  23. Tan LK, Yacoub S, Scott S, et al. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect Dis 2008; 8 : 449–54.
  24. Jiménez BC, Navarro M, Huerga H, et al. Spontaneous splenic rupture due to Plasmodium vivax in a traveler: case report and review. J Travel Med 2007; 14 : 188–91.
  25. Prakash J, Singh AK, Kumar NS, et al. Acute renal failure in Plasmodium vivax malaria. J Assoc Physicians India 2003; 51 : 265–7.
  26. Choi HJ, Lee SY, Yang H, et al. Retinal haemorrhages in vivax malaria. Trans R Soc Trop Med Hyg 2004; 98 : 387–9.
  27. Rodríguez-Morales AJ, Sánchez E, Vargas M, et al. Is anemia in Plasmodium vivax malaria more frequent and severe than in Plasmodium falciparum? Am J Med 2006; 119 : e9–10.
  28. Obaldía N 3rd. Clinico-pathological observations on the pathogenesis of severe thrombocytopenia and anemia induced by Plasmodium vivax infections during antimalarial drug efficacy trials in Aotus monkeys. Am J Trop Med Hyg 2007; 77 : 3–13.
  29. Lawn SD, Krishna S, Jarvis JN, et al. Case reports: pernicious complications of benign tertian malaria. Trans R Soc Trop Med Hyg 2003; 97 : 551–3.
  30. Ozen M, Gungor S, Atambay M, et al. Cerebral malaria owing to Plasmodium vivax: case report. Ann Trop Paediat 2006; 26 : 141–4.
  31. Wickramasinghe SN, Looareesuwan S, Nagachinta B, et al. Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria. Br J Haematol 1989; 72 : 91–9.
  32. Rodríguez-Morales AJ, Sánchez E, Vargas M, et al. Occurrence of thrombocytopenia in Plasmodium vivax malaria. Clin Infect Dis 2005; 41 : 130–1.
  33. Agarwal R, Nath A, Gupta D. Noninvasive ventilation in Plasmodium vivax related ALI/ARDS. Intern Med 2007; 46 : 2007–11.
  34. Anstey NM, Handojo T, Pain MC, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis 2007; 195 : 589–96.
  35. Marsden PD, Bruce-Chwatt LJ. Cerebral malaria. Contemp Neurol Ser 1975; 12 : 29–44.
  36. Beg MA, Khan R, Baig SM, et al. Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg 2002; 67 : 230–2.
  37. Kochar DK, Saxena V, Singh N, et al. Plasmodium vivax malaria. Emerg Infect Dis 2005; 11 : 132–4.
  38. Nosten F, McGready R, Simpson JA, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999; 354 : 546–9.
  39. Hemmer CJ, Holst FG, Kern P, et al. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 2006; 11 : 817–23.
  40. Zeyrek FY, Kurcer MA, Zeyrek D, et al. Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey. Parasite Immunol 2006; 28 : 201–7.
  41. Karunaweera N, Wanasekara D, Chandrasekharan V, et al. Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation. Malar J 2007; 6 : 62.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.